Imunon logo
Imunon
IMNN | NASDAQ
Chart Builder DCF Calculator
$0.59
-$0.04 (-6.20%)
At close: Nov 16, 2026, 4:00 PM ET
$0.59
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:46 PM ET

Imunon Company Profile

Company profile explained

Company Profile

Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. The company's pipeline features GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a proprietary heat-activated liposomal formulation of doxorubicin, currently in development for various cancer indications. Additionally, Imunon possesses two feasibility-stage platform technologies aimed at creating nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Established in 1982 and based in Lawrenceville, New Jersey, the firm was known as Celsion Corporation before rebranding to Imunon, Inc. in September 2022.

Key Executives

Name Position
Stacy R. Lindborg President, Chief Executive Officer & Director
Douglas V. Faller Chief Medical Officer
Joshua Blacher Interim CFO, Principal Financial Officer & Principal Accounting Officer
Kristin Longobardi Senior Vice President of Strategic Operations
Michael H. Tardugno Executive Chairman
Stephen G. Machatha Senior Vice President of Technical Operations
Susan Mary Eylward General Counsel & Corporate Secretary

Latest SEC Filings

Date Type Title
Oct 28, 2026 S-1/A [Amend] Filing
Oct 27, 2026 4 Filing
Oct 27, 2026 4 Filing
Oct 27, 2026 4 Filing
Oct 27, 2026 S-1 Filing
Oct 27, 2026 8-K Current Report
Oct 21, 2026 8-K Current Report
Oct 13, 2026 4 Filing
Oct 13, 2026 4 Filing
Oct 13, 2026 4 Filing
View All SEC Filings ➞
Imunon
Imunon logo
Country United States
IPO Date Mar 1, 1999
Industry Biotechnology
Sector Healthcare
Employees 20
CEO Stacy R. Lindborg

Contact Details

997 Lenox Drive Lawrenceville, New Jersey 08648 United States

Stock Details

Ticker Symbol IMNN
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000749647
CUSIP Number 15117N701
ISIN Number US15117N7012
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.